Pharmaceutical composition including antibody specifically binding to ErbB3 for preventing or treating drug-resistance cancer and method using the same
KR101746152B1
Antibody specifically binding to ErbB3 and use thereof
Glucocerebrosidase conjugates with modified biocompatible polymer, preparation method thereof and pharmaceutical composition comprising the same for treating gaucher's disease
MX2008009830A
Bst2 inhibitor.
CA2635467A1
Bst2 inhibitor
KR20080111347A
Recombinant antibodies capable of binding to a cancer specific marker and uses thereof
KR20080105735A
A process for preparing an additionally glycosylated recombinant alpha-galactosidase and an additionally glycosylated recombinant alpha-galactosidase prepared therewith
KR20080054120A
Enzyme-linked immunosorbent assay method for residual host cell derived proteins in recombinant antibody drug production
KR100721927B1
A method of separating tumor cells from cancer tissue
